Vasconcelos, Luiza [UNESP]Vieira, Erica Cristina [UNESP]Minicucci, Eliana Maria [UNESP]Salvio, Ana Gabriela [UNESP]Souza, Mair Pedro de [UNESP]Marques, Mariângela Esther Alencar [UNESP]Marques, Silvio Alencar [UNESP]2014-12-032014-12-032013-09-01Anais Brasileiros De Dermatologia. Rio De Janeiro Rj: Soc Brasileira Dermatologia, v. 88, n. 5, p. 799-802, 2013.0365-0596http://hdl.handle.net/11449/112209Graft-versus-host disease is observed mainly in recipients of hematopoietic cell transplantation and is expressed by cutaneous or systemic signals and symptoms. Graft-versus-host disease is clinically classified as acute or chronic. Chronic Graft-versus-host disease occurs in up to 70% of hematopoietic cell transplanted patients and its clinical manifestations have important impact on morbidity and quality of life. The authors report an expressive cutaneous, oral and adnexal involvement in a patient with chronic Graft-versus-host disease with multiple lesions of lichenoid and atrophic pattern.799-802engBone marrow transplantationClinical evolutionGraft vs host diseaseLichen sclerosus et atrophicusArtigo10.1590/abd1806-4841.20132128S0365-05962013000500799WOS:000328202900015Acesso abertoS0365-05962013000500799.pdf87894804583775527528116925519142